Salivary gland epithelial cells (SGEC): Carriers of exquisite B7-2 (CD86) costimulatory molecules

被引:12
作者
Kapsogeorgou, Efstathia K. [1 ]
Manoussakis, Menelaos N. [1 ]
机构
[1] Natl Univ Athens, Dept Pathophysiol, Sch Med, Athens 11527, Greece
关键词
Salivary gland epithelial cells; B7-2 (CD86) costimulatory molecules; B7-2 (CD86) alternate transcripts; Sjogren's syndrome; HUMAN T-LYMPHOCYTES; SPLICE VARIANT; FUNCTIONAL EXPRESSION; AUTOIMMUNE-DISEASE; SJOGRENS-SYNDROME; IMMUNE-RESPONSES; CTLA-4; CD28; LIGANDS; ACTIVATION;
D O I
10.1016/j.jaut.2010.06.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Costimulatory molecules are cell-surface glycoproteins that can direct, modulate and fine tune immune responses. B7-2(CD86) costimulatory molecules are considered as major regulators of T cell responses, acting by appropriate interactions with the stimulatory CD28 or inhibitory CTLA-4 receptors found on T cells. Although their expression is thought to be restricted in lymphoid cells, evidence raised during the last decade show their expression in other types of cells, including human non-neoplastic salivary gland epithelial cells (SGEC). The expression of B7-2 molecules by SGECs requires special attention, due to their unique expression pattern and distinctive binding properties. Thus, SGECs express three B7-2 alternate transcripts that encode the full-length protein, the soluble form and a truncated membrane-bound molecule, that lacks the IgV-like counter-receptor binding domain and has a negative regulatory role. A similar pattern of expression is observed in monocytes, but not in several other types of cells, including dendritic cells. Furthermore, the full-length B7-2 molecules in SGEC display unique binding properties, denoted by the functional interaction with CD28 receptor, but reduced binding of the negative regulator CTLA-4. These distinctive features suggest the tight regulation of B7-2 molecules expression and indicate the key immunoregulatory role of SGECs. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:188 / 191
页数:4
相关论文
共 49 条
[1]   Navigating the passage between Charybdis and Scylla: Recognizing the achievements of Noel Rose [J].
Ansari, Aftab A. ;
Gershwin, M. Eric .
JOURNAL OF AUTOIMMUNITY, 2009, 33 (3-4) :165-169
[2]   Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis;: influence of H-pylori eradication [J].
Archimandritis, A ;
Sougioultzis, S ;
Foukas, PG ;
Tzivras, M ;
Davaris, P ;
Moutsopoulos, HM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (03) :464-471
[3]   B70 ANTIGEN IS A 2ND LIGAND FOR CTLA-4 AND CD28 [J].
AZUMA, M ;
ITO, D ;
YAGITA, H ;
OKUMURA, K ;
PHILLIPS, JH ;
LANIER, LL ;
SOMOZA, C .
NATURE, 1993, 366 (6450) :76-79
[4]   B7-1 and B7-2: Similar costimulatory ligands with different biochemical, oligomeric and signaling properties [J].
Bhatia, S ;
Edidin, M ;
Almo, SC ;
Nathenson, SG .
IMMUNOLOGY LETTERS, 2006, 104 (1-2) :70-75
[5]  
BORRIELLO F, 1995, J IMMUNOL, V155, P5490
[6]   B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation [J].
Borriello, F ;
Sethna, MP ;
Boyd, SD ;
Schweitzer, AN ;
Tivol, EA ;
Jacoby, D ;
Strom, TB ;
Simpson, EM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1997, 6 (03) :303-313
[7]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53
[8]   The interaction properties of costimulatory molecules revisited [J].
Collins, AV ;
Brodie, DW ;
Gilbert, RJC ;
Iaboni, A ;
Manso-Sancho, R ;
Walse, B ;
Stuart, DI ;
van der Merwe, PA ;
Davis, SJ .
IMMUNITY, 2002, 17 (02) :201-210
[9]   CD28/CTLA-4 LIGANDS - THE GENE ENCODING CD86 (B70/B7.2) MAPS TO THE SAME REGION AS CD80 (B7/B7.1) GENE IN HUMAN-CHROMOSOME 3Q13-Q23 [J].
FERNANDEZRUIZ, E ;
SOMOZA, C ;
SANCHEZMADRID, F ;
LANIER, LL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1453-1456
[10]   Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways [J].
Fife, Brian T. ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2008, 224 :166-182